Skip to main content
SpringerLink
Log in

On the anxiogenic and anxiolytic nature of long-term cerebral 5-HT depletion following MDMA

  • Letter to the Editors
  • Published:
Psychopharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Blokland A, Lieben CKJ, van Oorsouw KIM, Deutz NEP (2001) A new method for lowering plasma tryptophan concentrations: no effect on affective behavior but impaired object memory in rats. Soc Neurosci Abstr 27:319-311

    Google Scholar 

  • Blokland A, Lieben C, Deutz NEP (2002) Anxiogenic and depressive-like effects, but no cognitive deficits, after repeated moderate tryptophan depletion in rat. J Psychopharmacol 16:39-49

    Google Scholar 

  • Briley M, Chopin P, Moret C (1990) Effect of serotonergic lesion on “anxious” behaviour measured in the elevated plus-maze test in the rat. Psychopharmacology 101:187-189

    Google Scholar 

  • Brown CM, Fletcher PJ, Coscina DV (1998) Acute amino acid loads that deplete brain serotonin fail to alter behavior. Pharmacol Biochem Behav 59:115-121

    Google Scholar 

  • Colado MI, Murray TK, Green AR (1993) 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), pchloroamphetamine and fenfluramine administration and the effects of chlormethiazole and dizocilpine. Br J Pharmacol 108:583-589

    Google Scholar 

  • File SE, Zangrossi H, Viana M, Graeff FG (1993) Trial 2 in the elevated plus-maze - a different form of fear. Psychopharmacology 111:491-494

    Google Scholar 

  • Fone KCF, Beckett SRG, Topham IA, Swettenham J, Ball M, Maddocks L (2002) Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity. Psychopharmacology 159:437-444

    Google Scholar 

  • Gamma A, Frei E, Lehmann D, Pascual-Marqui RD, Hell D, Vollenweider FX (2000) Mood state and brain electric activity in Ecstasy users. Neuroreport 11:157-162

    Google Scholar 

  • Griebel G (1995) 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Pharmacol Ther 65:319-395

    Google Scholar 

  • Gurtman CG, Morley KC, Li KM, Hunt GE, McGregor IS (2002) Increased anxiety in rats after 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy): association with serotonin depletion. Eur J Pharmacol (in press)

  • Hall FS, Devries AC, Fong GW, Huang S, Pert A (1999) Effects of 5,7-dihydroxytryptamine depletion of tissue serotonin levels on extracellular serotonin in the striatum assessed with in vivo microdialysis: relationship to behavior. Synapse 33:16-25

    Google Scholar 

  • Hogg S (1996) A review of the validity and variability of the elevated plus-maze animal model of anxiety. Pharmacol Biochem Behav 54:21-30

    Google Scholar 

  • Iversen SD (1984) 5-HT and anxiety. Neuropharmacology 23:1553-1560

    Google Scholar 

  • McCann UD, Eligulashvili V, Mertl M, Murphy DL, Ricaurte GA (1999) Altered neuroendocrine and behavioral responses to mchlorophenylpiperazine in 3,4-methylene methamphetamine (MDMA) users. Psychopharmacology 147:56-65

    Google Scholar 

  • Mechan AO, Moran PM, Elliott JM, Young AMJ, Joseph MH, Green AR (2002a) A comparison between Dark Agouti and Sprague-Dawley rats in their behaviour on the elevated plusmaze, open-field apparatus and activity meters, and their response to diazepam. Psychopharmacology 159:188-195

    Google Scholar 

  • Mechan AO, Moran PM, Elliott JM, Young AMJ, Joseph MH, Green AR (2002b) A study of the effects of a single neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) on the subsequent long-term behaviour of rats in the plus maze and open field. Psychopharmacology 159:167-175

    Google Scholar 

  • Morgan MJ (1998) Recreational use of ecstasy (MDMA) is associated with increased impulsivity. Neuropsychopharmacology 19:252-264

    Google Scholar 

  • Morley KC, Gallate JE, Hunt GE, Mallet PE, McGregor IS (2001) Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine (Ecstasy). Eur J Pharmacol 433:91-99

    Google Scholar 

  • Parrott AC (2001) Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research. Hum Psychopharmacol 16:557-577

    Google Scholar 

  • Parrott AC, Sisk E, Turner JD (2000) Psychobiological problems in heavy ecstasy (MDMA) polydrug users. Drug Alcohol Depend 60:105-110

    Google Scholar 

  • Soubrie P (1986) Reconciling the role of central serotonin neurons in human and animal behaviour. Behav Brain Sci 9:319-364

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmacology Research Group, School of Pharmacy, De Montfort University, LE1 9BH, Leicester, UK

    A. Richard Green

  2. AstraZeneca R & D Charnwood, LE11 5RH, Loughborough, UK

    A. Richard Green

  3. School of Psychology, A19, University of Sydney, 2006, Sydney, NSW, Australia

    Iain S. McGregor

Authors
  1. A. Richard Green
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Iain S. McGregor
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Richard Green.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Green, A.R., McGregor, I.S. On the anxiogenic and anxiolytic nature of long-term cerebral 5-HT depletion following MDMA. Psychopharmacology 162, 448–450 (2002). https://doi.org/10.1007/s00213-002-1158-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-002-1158-3

Keywords

Search

Navigation